CHRONIC MUCOCUTANEOUS CANDIDIASIS - SUCCESSFUL TREATMENT WITH INTERMITTENT ORAL DOSES OF CLOTRIMAZOLE

被引:5
作者
ROCKOFF, AS
机构
关键词
D O I
10.1001/archderm.115.3.322
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:322 / 323
页数:2
相关论文
共 32 条
[1]   CHEMOTHERAPY OF SYSTEMIC MYCOSES (FIRST OF 2 PARTS) [J].
BENNETT, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (01) :30-32
[2]   CLOTRIMAZOLE (BAY B 5097) - IN-VITRO AND CLINICAL PHARMACOLOGICAL STUDIES [J].
BURGESS, MA ;
BODEY, GP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (06) :423-&
[3]  
COHEN M, 1974, POSTGRAD MED J, V50, P28
[4]   CLINICAL PERSPECTIVE, IMMUNE DEFENSE-MECHANISMS, AND CURRENT CONCEPTS OF THERAPY [J].
EDWARDS, JE ;
LEHRER, RI ;
STIEHM, ER ;
FISCHER, TJ ;
YOUNG, LS .
ANNALS OF INTERNAL MEDICINE, 1978, 89 (01) :91-106
[5]   MICONAZOLE IN TREATMENT OF CHRONIC MUCOCUTANEOUS CANDIDIASIS - PRELIMINARY-REPORT [J].
FISCHER, TJ ;
KLEIN, RB ;
KERSHNAR, HE ;
BORUT, TC ;
STIEHM, ER .
JOURNAL OF PEDIATRICS, 1977, 91 (05) :815-819
[6]   TREATMENT OF FUNGAL INFECTIONS WITH FLUCYTOSINE [J].
HARDER, EJ ;
HERMANS, PE .
ARCHIVES OF INTERNAL MEDICINE, 1975, 135 (02) :231-237
[7]  
HIGGS JM, 1973, BRIT J DERMATOL, V89, P179, DOI 10.1111/j.1365-2133.1973.tb02955.x
[8]   DEVELOPMENT OF RESISTANCE TO 5-FLUOROCYTOSINE IN CANDIDA-PARAPSILOSIS DURING THERAPY [J].
HOEPRICH, PD ;
INGRAHAM, JL ;
KLEKER, E ;
WINSHIP, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (02) :112-118
[9]  
HOLT RJ, 1972, DEV MED CHILD NEUROL, V14, P70
[10]   LABORATORY ASSESSMENT OF ANTIMYCOTIC DRUG CLOTRIMAZOLE [J].
HOLT, RJ ;
NEWMAN, RL .
JOURNAL OF CLINICAL PATHOLOGY, 1972, 25 (12) :1089-1097